Heart valve trial asks: do we really need that extra artery test?
NCT ID NCT06898086
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at people with severe aortic stenosis who need a new heart valve (TAVI). Normally, doctors do a coronary angiogram first to check for blocked arteries. But this test can cause kidney damage or bleeding, especially in older patients. The trial will compare the usual approach to a simpler one without the angiogram, to see if it is just as safe and effective. About 620 participants across Europe will be followed for two years.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Transcatheter aortic valve implantation (TAVI) using the Myval™ heart valve
- What this could lead to
- If successful, this could simplify the TAVI procedure for many patients, reducing risks like kidney injury and bleeding from unnecessary angiography.
- What could go wrong
- This is a non-inferiority trial, so it may only show that skipping angiography is not worse than the standard approach. The results may not apply to patients with chest pain or those who had prior coronary procedures.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE AORTIC STENOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AOUP- Azienda Ospedaliera Universitaria Pisana
NOT_YET_RECRUITINGPisa, Basel-Stadt, 56126, Italy
-
Azienda Ospedaliera Universitaria Senese
NOT_YET_RECRUITINGSiena, 53100, Italy
-
Azienda Ospedaliero Policlinico Universitaria G. Rodolico- San Marco Catania
NOT_YET_RECRUITINGCatania, 95123, Italy
-
Azienda Sanitaria Universitaria Integrata di Trieste
NOT_YET_RECRUITINGTrieste, 34128, Italy
-
Clinical Trial Center Maastricht B.V
NOT_YET_RECRUITINGMaastricht, 6229, Netherlands
-
Clinique Pasteur
NOT_YET_RECRUITINGToulouse, 31076, France
-
Elisabeth Krankenhaus Essen
NOT_YET_RECRUITINGEssen, 45138, Germany
-
Fondazione Policlinico Universitario Campus Biomedico
RECRUITINGRoma, 00128, Italy
-
IRCCS ISMETT Palermo
NOT_YET_RECRUITINGPalermo, Basel-Stadt, 90127, Italy
-
Institut Arnault Tzanck
NOT_YET_RECRUITINGNice, 06700, France
-
Klinikum Klagenfurt am Wörthersee
NOT_YET_RECRUITINGKlagenfurt, 9020, Austria
-
Královské Vinohrady University Hospital
NOT_YET_RECRUITINGPrague, 10034, Czechia
-
Medical University Graz
RECRUITINGGraz, 8036, Austria
-
Nemocnice Na Homolce
NOT_YET_RECRUITINGPrague, 15030, Czechia
-
OLVG Hospital Amsterdam
NOT_YET_RECRUITINGAmsterdam, 1091, Netherlands
-
Ospedale dell'Angelo - ULSS 3 Serenissima
NOT_YET_RECRUITINGMestre, 30174, Italy
-
Stichting Amsterdam UMC
NOT_YET_RECRUITINGAmsterdam, 1081, Netherlands
-
University Hospital Basel
RECRUITINGBasel, Canton of Basel-City, 4031, Switzerland
-
University Hospital Zurich
NOT_YET_RECRUITINGZurich, 8091, Switzerland
-
Universitätsklinikum Düsseldorf
NOT_YET_RECRUITINGDüsseldorf, North Rhine-Westphalia, 40221, Germany
-
Universitätsklinikum Freiburg- Universitäts-Herzzentrum Campus Bad Krozingen
NOT_YET_RECRUITINGFreiburg im Breisgau, 79189, Germany
-
Universitätsklinikum Schleswig-Holstein - Campus Lübeck
NOT_YET_RECRUITINGLübeck, 23562, Germany
-
Universitätsklinikum Ulm
NOT_YET_RECRUITINGUlm, 89081, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A new heart valve without Open-Heart surgery: can it help High-Risk patients?
- Could a common blood pressure pill protect the heart after valve replacement?
- Heart valve unit may cut brain fog after procedure, study hopes
- AI-Powered ultrasound could replace CT for heart valve diagnosis
- New study aims to simplify care for patients with multiple leaky heart valves
- New registry to monitor Long-Term success of keyhole heart valve treatments